Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07098728Recruiting
Randomised, open-label trial of levetiracetam in status epilepticus (SE) (2 arms), sponsored by Ministry of Health and Sports. Primary endpoint: Clinical cessation of seizure. Started Jul 2025; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07098728.